
Pseudoprogression in Rectal Gastrointestinal Stromal Tumor
Author(s) -
Virendra Kumar Meena,
Binit Sureka,
Poonam Elhence,
Mayuresh Gautam,
Pawan Kumar Garg,
Pushpinder Singh Khera
Publication year - 2019
Publication title -
indian journal of medical and paediatric oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 22
eISSN - 0975-2129
pISSN - 0971-5851
DOI - 10.4103/ijmpo.ijmpo_148_17
Subject(s) - medicine , gist , stromal tumor , gastrointestinal tract , radiology , imatinib , differential diagnosis , abdomen , stromal cell , pathology , myeloid leukemia
Although gastrointestinal stromal tumors (GISTs) are common mesenchymal intestinal neoplasms, rectal GISTs are rare mesenchymal tumors of the GI tract. We describe a case of rectal GIST in a 63-year-old male. The patient was given imatinib monotherapy and was further followed up by contrast-enhanced computed tomography abdomen for response assessment. We conclude that although rectal GISTs are extremely uncommon, it should be considered as a differential when any rectal mass is incidentally detected. Oncologists and radiologists should also be aware of pseudoprogression phenomena of GISTs in evaluating tumor response.